Verapamil 2.5mg/ml Inj, 5x2ml Vial
Overview
What is this medicine?
How to Use This Medicine
For proper storage and disposal, consult with your doctor, nurse, or pharmacist to determine the best approach if you need to store the medication at home.
If you miss a dose, contact your doctor promptly to receive guidance on the next steps to take.
Lifestyle & Tips
- This medication is typically administered in an acute care setting, so lifestyle modifications are not directly applicable during administration.
- Patients should follow their doctor's advice regarding diet, exercise, and other medications once discharged.
Available Forms & Alternatives
Available Strengths:
- Verapamil 120mg ER Capsules
- Verapamil 240mg ER Capsules
- Verapamil 180mg ER Capsules
- Verapamil 40mg Tablets
- Verapamil 360mg SR Capsules
- Verapamil 2.5mg/ml Inj, 4ml
- Verapamil 80mg Tablets
- Verapamil 120mg Tablets
- Verapamil ER 100mg Caps PM (24 Hr)
- Verapamil ER 200mg Capsules (24 Hr)
- Verapamil ER 300mg Capsules (24 Hr)
- Verapamil ER 240mg Tablets
- Verapamil 2.5mg/ml Inj, 2ml
- Verapamil ER 180mg Tablets
- Verapamil ER 120mg Tablets
- Verapamil 80mg Tablets
- Verapamil 2.5mg/ml Inj, 4ml
- Verapamil 2.5mg/ml Inj, 5x2ml Vial
- Verapamil 40mg Tablets
- Verapamil 120mg Tablets
- Verapamil ER 300mg Capsules
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical help right away:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of liver problems, including:
+ Dark urine
+ Tiredness
+ Decreased appetite
+ Upset stomach or stomach pain
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes
Slow heartbeat
Abnormal heartbeat that is new or worsening
Severe dizziness or fainting
Shortness of breath, significant weight gain, or swelling in the arms or legs
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor:
Dizziness or headache
Constipation
Reporting Side Effects
This list is not exhaustive, and you may experience other side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe dizziness or lightheadedness
- Fainting
- Slow or irregular heartbeat
- Shortness of breath
- Swelling in the ankles or feet
- Chest pain
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Describe the allergic reaction you experienced, including the symptoms that occurred.
Certain health conditions, including:
+ Heart failure (a weakened heart)
+ Specific types of abnormal heart rhythms, such as heart block, Lown-Ganong-Levine syndrome, sick sinus syndrome, or Wolff-Parkinson-White syndrome
+ Low blood pressure
+ A slow heartbeat
Medications you are currently taking, including:
+ Dofetilide, ivabradine, or quinidine
+ Beta blockers like atenolol, metoprolol, or propranolol
+ Disopyramide or flibanserin, if taken within the last 48 hours
If you are breastfeeding, as you should not breastfeed while taking this medication
This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other medications and health conditions. Never start, stop, or change the dose of any medication without consulting your doctor.
Precautions & Cautions
When starting this medication, be cautious when driving or performing tasks that require your full attention, as it may affect your alertness. To minimize the risk of dizziness or fainting, get up slowly from a sitting or lying position, and be careful when navigating stairs.
Follow your doctor's instructions for monitoring your blood pressure and heart rate, and undergo blood tests as recommended. If you have high blood pressure, consult your doctor before taking any over-the-counter (OTC) products that may increase blood pressure, such as cough or cold medications, diet pills, stimulants, non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen, and certain natural products or aids.
Discuss your alcohol consumption with your doctor before drinking, and if you regularly consume grapefruit juice or eat grapefruit, inform your doctor as well.
If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects.
If you are pregnant or planning to become pregnant, consult your doctor to discuss the potential benefits and risks of using this medication during pregnancy.
Overdose Information
Overdose Symptoms:
- Profound hypotension (low blood pressure)
- Bradycardia (very slow heart rate)
- High-degree AV block (heart block)
- Asystole (cardiac arrest)
- Cardiogenic shock
- Metabolic acidosis
- Hyperglycemia
- Confusion
- Coma
What to Do:
Immediate medical attention is required. Treatment is supportive and may include IV calcium gluconate/chloride, atropine, vasopressors (e.g., norepinephrine), glucagon, high-dose insulin-glucose therapy, and cardiac pacing. Call 1-800-222-1222 (Poison Control) for further guidance.
Drug Interactions
Contraindicated Interactions
- Beta-blockers (IV, concurrent use or within a few hours): Risk of severe bradycardia, AV block, and myocardial depression.
- Disopyramide: Should not be administered within 48 hours before or 24 hours after verapamil due to potential for severe hypotension and cardiac arrest.
- Dantrolene (IV): Risk of hyperkalemia and myocardial depression.
- Ivabradine: Risk of excessive bradycardia.
- Colchicine (in patients with renal or hepatic impairment): Increased colchicine toxicity.
Major Interactions
- Digoxin: Verapamil increases serum digoxin levels by 50-75%. Reduce digoxin dose by 50% and monitor levels.
- Flecainide: Additive negative inotropic effects.
- Amiodarone: Additive effects on heart rate and AV conduction.
- Statins (e.g., Simvastatin, Lovastatin, Atorvastatin): Verapamil is a CYP3A4 inhibitor, increasing statin levels and risk of myopathy/rhabdomyolysis. Use lower statin doses or alternative statins (e.g., Pravastatin, Rosuvastatin).
- CYP3A4 inhibitors (e.g., Ketoconazole, Ritonavir, Clarithromycin): Increase verapamil levels, increasing risk of adverse effects.
- CYP3A4 inducers (e.g., Rifampin, Phenobarbital, Phenytoin, St. John's Wort): Decrease verapamil levels, reducing efficacy.
- Neuromuscular blockers (e.g., Vecuronium, Pancuronium): Verapamil may potentiate their effects, requiring lower doses.
- Oral Antidiabetics (e.g., Glyburide, Metformin): Verapamil may alter glucose tolerance.
- Theophylline: Verapamil may increase theophylline levels.
Moderate Interactions
- Alpha-blockers (e.g., Prazosin, Terazosin): Additive hypotensive effects.
- Clonidine: Additive effects on heart rate and AV conduction.
- Lithium: Verapamil may decrease lithium levels.
- Carbamazepine: Verapamil may increase carbamazepine levels, leading to toxicity.
- Cyclosporine, Tacrolimus, Sirolimus, Everolimus: Verapamil may increase levels of these immunosuppressants.
- Buspirone: Verapamil may increase buspirone levels.
- Midazolam, Triazolam: Verapamil may increase levels of these benzodiazepines.
- Quinidine: May cause hypotension in patients with hypertrophic cardiomyopathy.
Minor Interactions
- Aspirin: No significant interaction.
- NSAIDs: May reduce antihypertensive effect, but generally not clinically significant for acute IV use.
Monitoring
Baseline Monitoring
Rationale: To assess baseline rhythm, PR interval, QRS duration, and identify pre-existing conduction abnormalities (e.g., AV block, WPW) that are contraindications.
Timing: Prior to administration.
Rationale: To establish baseline and identify hypotension, a common adverse effect.
Timing: Prior to administration.
Rationale: To establish baseline and monitor for bradycardia.
Timing: Prior to administration.
Rationale: To assess for severe LV dysfunction or cardiogenic shock, which are contraindications.
Timing: Clinical assessment prior to administration.
Routine Monitoring
Frequency: Continuously during and after administration for at least 6 hours or until stable.
Target: Normal sinus rhythm or controlled ventricular rate (e.g., <100 bpm in AF/AFL); PR interval <0.20 seconds (unless therapeutic prolongation is desired and tolerated); absence of new AV block.
Action Threshold: Development of 2nd or 3rd degree AV block, significant bradycardia (<50 bpm), QRS widening, or signs of accessory pathway conduction (e.g., pre-excitation).
Frequency: Every 5 minutes during administration, then every 15 minutes for the first hour, then every 30-60 minutes until stable.
Target: Maintain systolic BP >90-100 mmHg (or patient's baseline).
Action Threshold: Systolic BP <90 mmHg or symptomatic hypotension.
Frequency: Continuously during and after administration.
Target: Maintain HR >50 bpm (unless desired therapeutic effect for SVT is lower and tolerated).
Action Threshold: HR <50 bpm or symptomatic bradycardia.
Frequency: As clinically indicated, especially in patients with heart failure.
Target: Adequate urine output.
Action Threshold: Signs of fluid overload or decreased urine output.
Symptom Monitoring
- Dizziness
- Lightheadedness
- Syncope
- Chest pain
- Shortness of breath
- Palpitations
- Fatigue
- Swelling in ankles/feet
Special Patient Groups
Pregnancy
Use in pregnancy only if the potential benefit justifies the potential risk to the fetus. Verapamil crosses the placenta. Category C.
Trimester-Specific Risks:
Lactation
Verapamil is excreted into breast milk. The American Academy of Pediatrics considers it compatible with breastfeeding, but monitor infant for bradycardia, hypotension, and sedation. L3 (Moderately Safe).
Pediatric Use
Use with extreme caution, especially in infants, due to increased risk of severe hypotension and bradycardia. Dosing is weight-based and requires careful titration and continuous monitoring. Contraindicated in infants with Wolff-Parkinson-White (WPW) syndrome and atrial fibrillation/flutter.
Geriatric Use
Elderly patients may be more sensitive to the hypotensive and bradycardic effects of verapamil due to age-related decreases in hepatic and renal function. Start with lower doses (e.g., 2.5-5 mg) and administer over 3 minutes. Monitor closely for adverse effects.
Clinical Information
Clinical Pearls
- Always administer IV verapamil slowly (over 2-3 minutes) to minimize the risk of hypotension and bradycardia.
- Ensure continuous ECG and blood pressure monitoring during and after administration.
- Have resuscitation equipment and medications (e.g., calcium gluconate/chloride, atropine, vasopressors) readily available.
- Verapamil is contraindicated in patients with wide complex tachycardias of unknown origin, as it can cause hemodynamic collapse in patients with ventricular tachycardia.
- Absolutely contraindicated in patients with atrial fibrillation/flutter and an accessory bypass tract (e.g., WPW syndrome) due to the risk of accelerating conduction down the accessory pathway, leading to ventricular fibrillation.
- Avoid concurrent IV beta-blocker administration or within a few hours of verapamil due to synergistic negative cardiac effects.
- Calcium gluconate/chloride can be used to reverse some of the cardiac depressant effects of verapamil in overdose or severe adverse reactions.
Alternative Therapies
- Adenosine (first-line for stable SVT)
- Diltiazem (another non-dihydropyridine CCB, similar indications)
- Beta-blockers (e.g., Metoprolol, Esmolol - for rate control in AF/AFL or certain SVTs, but contraindicated with verapamil)
- Digoxin (for chronic rate control in AF/AFL, less effective for acute SVT termination)
- Electrical cardioversion (for unstable tachyarrhythmias or refractory stable tachyarrhythmias)